Background Dyspnea that is refractory to conventional treatments affects up to 50% of patients
with advanced chronic obstructive pulmonary disease (COPD). Although professional …

Background The Halifax-based INSPIRED COPD Outreach Program™ is a facility-to-community
home-based novel clinical initiative that through improved care transitions, self-…

Recent trends show an increase in the prevalence and costs associated with managing
individuals with multimorbidities. Enabling better care for these individuals requires system-level …

The ‘Number Needed to Treat' (NNT) is a useful measure for estimating the number of patients
that would need to receive a therapeutic intervention to avoid one of the adverse events …

Rationale: The global prevalence of Chronic Obstructive Pulmonary Disease (COPD) is high
and rising. Locally, COPD is the second most common cause of hospital admission (~ 300 …

PURPOSE: Chronic obstructive pulmonary disease (COPD) is increasing in prevalence locally
and worldwide, imposing significant burdens on patients, families and on the healthcare …

PURPOSE: Symptom relief is a top priority for those living with advanced COPD. Recent ACCP
and CTS consensus statements support using opioids for refractory dyspnea, but patient/…

PURPOSE: Across Canada COPD is the primary cause of hospital admission. Risk of
readmission is high. Models of care, by focusing on acute episodes, are failing with significant …

Rationale: advanced disease efficiency of ventilation and removal of carbon dioxide declines
with concomitant risk of hypercapnia. As clinicians beyond Respirology move toward more …

RATIONALE: A consensus statement from the American College of Chest Physicians (ACCP)
and a clinical practice guideline from the Canadian Thoracic Society (CTS) recommend …